Outset Medical, Inc.
OM
$0.553
-$0.0005-0.09%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -12.80% | -13.00% | -9.94% | 5.74% | 13.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -12.80% | -13.00% | -9.94% | 5.74% | 13.00% |
| Cost of Revenue | -26.37% | -24.92% | -20.95% | -4.38% | 3.80% |
| Gross Profit | 34.38% | 34.25% | 38.98% | 55.99% | 63.34% |
| SG&A Expenses | -20.83% | -16.05% | -5.51% | 0.10% | 7.54% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -25.57% | -20.73% | -11.00% | -0.20% | 7.68% |
| Operating Income | 35.53% | 26.65% | 11.82% | 4.38% | -3.86% |
| Income Before Tax | 26.00% | 19.89% | 6.57% | 0.82% | -5.91% |
| Income Tax Expenses | -6.12% | 27.79% | 24.94% | 32.53% | 77.29% |
| Earnings from Continuing Operations | 25.94% | 19.76% | 6.50% | 0.74% | -6.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 25.94% | 19.76% | 6.50% | 0.74% | -6.04% |
| EBIT | 35.53% | 26.65% | 11.82% | 4.38% | -3.86% |
| EBITDA | 36.76% | 27.63% | 12.44% | 4.89% | -3.58% |
| EPS Basic | 28.80% | 22.69% | 10.36% | 4.07% | -2.89% |
| Normalized Basic EPS | 30.89% | 23.62% | 11.15% | 4.80% | -2.13% |
| EPS Diluted | 28.80% | 22.69% | 10.36% | 4.19% | -2.66% |
| Normalized Diluted EPS | 30.89% | 23.62% | 11.15% | 4.80% | -2.13% |
| Average Basic Shares Outstanding | 4.10% | 3.83% | 4.48% | 3.55% | 3.14% |
| Average Diluted Shares Outstanding | 4.10% | 3.83% | 4.48% | 3.55% | 3.14% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
